Skip to content

Debt-to-assets at other companies

Pfizer logo
PfizerPFE
0.3×0.0×
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
0.0×
CG Oncology logo
CG OncologyCGON
0.0×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
0.0×
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
+0.5×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
0.0×

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.4%
Enterprise value$923.07M+23.9%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Calculated from Oric Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s debt-to-assets?
Oric Pharmaceuticals, Inc. (ORIC) reported debt-to-assets of 0× in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s debt-to-assets changed year-over-year?
Oric Pharmaceuticals, Inc.'s debt-to-assets decreased by 43.2% year-over-year, from 0× to 0×.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s debt-to-assets?
Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s debt-to-assets has grown at a -18.7% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.